aspartic acid has been researched along with Angor Pectoris in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fedchyshyn, NR; Kapustynskyy, OO; Tkachenko, VI; Zaremba, OV; Zaremba, YK | 1 |
| Hamada, M; Hara, Y; Higaki, J; Kohara, K; Miki, T; Nakura, J; Ogimoto, A; Ohtsuka, T; Shigematsu, Y | 1 |
| Håkanson, E; Jorfeldt, L; Svedjeholm, R; Vanhanen, I | 1 |
| Cai, H; Colagiuri, S; Wang, X; Wilcken, DE | 1 |
| Khogali, SE; Pringle, SD; Rennie, MJ; Weryk, BV | 1 |
| Krüger, K | 1 |
| Dockweiler, J | 1 |
1 trial(s) available for aspartic acid and Angor Pectoris
| Article | Year |
|---|---|
Is glutamine beneficial in ischemic heart disease?
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Administration, Oral; Aged; Angina Pectoris; Animals; Aspartic Acid; Cardiac Output; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Exercise Test; Glutamic Acid; Glutamine; Glutathione; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Rats; Rats, Sprague-Dawley; Time Factors | 2002 |
6 other study(ies) available for aspartic acid and Angor Pectoris
| Article | Year |
|---|---|
THE INCREASE OF EFFICIENCY OF TREATMENT IN PATIENTS WITH NON-STABLE ANGINA PECTORIS WITH USE OF NITROGEN OXIDE DONATOR
Topics: Aged; Angina Pectoris; Arginine; Aspartic Acid; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Ukraine; Vasodilation; Vasodilator Agents | 2018 |
Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) in patients with coexistent hypertrophic cardiomyopathy and coronary spastic angina.
Topics: Amino Acid Substitution; Angina Pectoris; Aspartic Acid; Cardiomyopathy, Hypertrophic; Female; Glutamine; Humans; Japan; Male; Middle Aged; Nitric Oxide Synthase Type III; Polymorphism, Genetic; Risk Factors | 2005 |
Intravenous aspartate infusion after a coronary operation: effects on myocardial metabolism and hemodynamic state.
Topics: Alanine; Angina Pectoris; Aspartic Acid; Blood Glucose; Cardiac Catheterization; Coronary Artery Bypass; Fatty Acids, Nonesterified; Glucose; Glutamic Acid; Heart; Heart Arrest, Induced; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Lactates; Lung; Male; Middle Aged; Myocardium; Oxygen; Oxygen Consumption; Vascular Resistance | 1998 |
A common Glu298-->Asp (894G-->T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes.
Topics: Albuminuria; Amino Acid Substitution; Angina Pectoris; Aspartic Acid; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Exons; Genotype; Glutamic Acid; Humans; Middle Aged; Myocardial Infarction; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peripheral Vascular Diseases; Point Mutation; Risk Factors | 1998 |
[Metabolic therapeutic possibilities of ischemic heart disease].
Topics: Angina Pectoris; Aspartic Acid; Coronary Disease; Electrocardiography; Female; Humans; Hypertension; Magnesium; Male; Middle Aged; Myocardium; Nitroglycerin; Pain; Potassium; Prenylamine | 1967 |
[Treatment of coronary heart disease from the modern point of view].
Topics: Adult; Angina Pectoris; Animals; Aspartic Acid; Blood Circulation; Coronary Disease; Coronary Vessels; Electrocardiography; Electrolytes; Ethylenediamines; Female; Headache; Humans; Male; Middle Aged; Myocardial Infarction; Stress, Physiological; Vasodilator Agents | 1968 |